文献速递神经与头颈病理细胞病理与分子病理

基于NGS的连接依赖多重RT-PCR检测涎腺与鼻窦肿瘤融合基因

Detection of salivary gland and sinonasal fusions by a next-generation sequencing based, ligation-dependent, multiplex RT-PCR assay.
PubMed 文献 · Histopathology · 2023-06-22

该研究开发了一种基于连接依赖RT-PCR的多重NGS方法,可检测116个基因参与的96种融合转录本,并在180例涎腺与鼻窦肿瘤中验证。方法检出97.8%(176/180)病例的框内融合转录本,与常规技术(IHC、FISH、RT-PCR)结果一致率为97.8%(176/180)。该方法稳健、灵敏,适用于常规临床样本的融合基因检测。

要点

  • 多重NGS LD-RT-PCR可检测涎腺与鼻窦肿瘤中116个基因的96种融合。
  • 在180例肿瘤中融合转录本检出率为97.8%(176/180)。
  • 与常规技术结果一致率为97.8%(176/180),支持临床诊断应用。

核心结论

  • 该靶向多重NGS LD-RT-PCR方法稳健、高度灵敏,可从常规临床涎腺与鼻窦肿瘤样本中检测复发性基因融合。

研究设计与样本

  • 开发靶向多重NGS结合连接依赖RT-PCR的方法,检测116个基因参与的96种融合转录本。
  • 纳入180例涎腺与鼻窦肿瘤(141例标本和39例空芯针活检,均为FFPE样本),来自REFORpath网络。
  • 病例先前已通过FISH、RT-PCR或分子免疫组化鉴定融合基因,用于验证方法的特异性和灵敏度。

主要发现

  • 在97.8%(176/180)的病例中检测到框内融合转录本。
  • 基因融合检测结果与常规技术(IHC、FISH、RT-PCR)在176/180例肿瘤(97.8%)中一致。
  • 测试肿瘤涵盖14种主要肿瘤类型,包括分泌性癌、黏液表皮样癌、腺样囊性癌等。

临床怎么用

  • 该方法可用于常规临床涎腺与鼻窦肿瘤样本的融合基因检测。
  • 方法易于定制以覆盖新发现的融合,有望整合入NGS系统快速检测遗传异常。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The discovery of tumour type-specific gene fusion oncogenes in benign and malignant salivary gland and sinonasal (SGSN) tumours has significantly increased our knowledge about their molecular pathology and classification. METHODS AND RESULTS: We developed a new targeted multiplexed next-generation sequencing (NGS)-based method that utilizes ligation dependent reverse-transcriptase polymerase chain reaction (LD-RT-PCR) to detect oncogenic fusion transcripts involving 116 genes, leading to 96 gene fusions known to be recurrently rearranged in these tumours. In all, 180 SGSN tumours (formalin-fixed, paraffin-embedded samples, 141 specimens and 39 core needle biopsies) from the REFCORpath (French network for rare head and neck cancers) with previously identified fusion genes by fluorescent in situ hybridisation (FISH), RT-PCR, or molecular immunohistochemistry were selected to test its specificity and sensitivity and validate its diagnostic use. Tested tumours encompassed 14 major tumours types, including secretory carcinoma, mucoepidermoid carcinoma, adenoid cystic carcinoma, salivary gland intraductal carcinoma, clear cell carcinoma, pleomorphic adenoma, adamantinoma-like Ewing Sarcoma, EWSR1::COLCA2 sinonasal sarcoma, DEK::AFF2 sinonasal carcinoma, and biphenotypic sinonasal sarcoma. In-frame fusion transcripts were detected in 97.8% of cases (176/180). Gene fusion assay results correlated with conventional techniques (immunohistochemistry [IHC], FISH, and RT-PCR) in 176/180 tumours (97.8%). CONCLUSION: This targeted multiplexed NGS-based LD-RT-PCR method is a robust, highly sensitive method for the detection of recurrent gene fusions from routine clinical SGSN tumours. It can be easily customized to cover new fusions. These results are promising for implementing an integrated NGS system to rapidly detect genetic aberrations, facilitating accurate, genomics-based diagnoses, and accelerate time to precision therapies in SGSN tumours.

来源:Histopathology,查看原文。版权归原作者所有。

引用

  1. Lanic MD, Guérin R, Wassef M, et al. Detection of salivary gland and sinonasal fusions by a next-generation sequencing based, ligation-dependent, multiplex RT-PCR assay. Histopathology. 2023. PMID: 37350081. doi:10.1111/his.14971

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。